brain imaging News
-
Inscopix Expands Strategic Partnership with GRINTECH to Become Exclusive Global Supplier of GRIN lenses
Inscopix, Inc., a neuroscience company helping decode the brain for tomorrow’s treatments, announced that it is expanding its strategic supplier partnership with leading gradient index (GRIN) lens manufacturer GRINTECH GmbH to be the sole exclusive seller of GRIN lenses for neuroscience research applications. Inscopix offers innovative miniature-microscope (miniscope) based imaging ...
-
FUJIFILM VisualSonics Celebrates the First Installation of the Vevo F2 with Photoacoustics
FUJIFILM VisualSonics Inc., a world leader in ultra-high frequency ultrasound and photoacoustic imaging systems, and subsidiary of FUJIFILM SonoSite, Inc., recently celebrated the first installation of the new Vevo F2 imaging platform with photoacoustics at the Université de Tours, Tours, France, thanks to financial contributions from Région Centre Val de Loire and European Union. ...
-
Arterys Partners With Combinostics to Accelerate Accurate and Consistent Evaluations of Patients With Neurodegenerative Disease and Multiple Sclerosis
SAN FRANCISCO, November 26, 2021 (Newswire.com) - Arterys, the world's leading vendor neutral AI platform, today announced its partnership with Combinostics to make their AI imaging solution, cNeuro® available on the Arterys Platform. This partnership enables Arterys to have the most comprehensive Neuro AI suite on the market covering a broad set of applications in neuroradiology. Arterys ...
By Arterys Inc.
-
Prenatal exposure to insecticide Chlorpyrifos linked to alterations in brain structure and cognition
While No Longer Registered for Household Use in the U.S., the Insecticide Is Widely Used Around the World and in U.S. Agriculture Even low to moderate levels of exposure to the insecticide chlorpyrifos during pregnancy may lead to long-term, potentially irreversible changes in the brain structure of the child, according to a new brain imaging study by researchers from the Columbia Center for ...
-
Qynapse to Present New Evidence on the Value of QyScore for the Diagnosis and Monitoring of Multiple Sclerosis at ACTRIMS Forum 2022
BOSTON, MA, February 14, 2022, PRNewswire – Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, is pleased to present 2 posters at the annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2022, on February 24-26, in West Palm Beach, FL. The posters ...
By Qynapse
-
How the brain-eye connection aims to make memory loss a souvenir
In fact, nearly 40% of people over the age of 65 suffer from some form of memory loss. Understanding the causes of memory loss There’s currently no cure for Alzheimer’s or Alzheimer’s related dementia, early detection can give patients more control over how they manage their overall well-being. That includes managing their brain health to reduce certain risk factors, ...
-
Focussing on Australia`s second biggest killer
The cluster will conduct the START (Stroke, imaging, pRevention and Treatment) cohort study of stroke which is designed to integrate imaging and biomarker analysis to identify patients at risk of stroke. Those strategies will then be used to develop preventative measures for those patients. The START Cohort will collect and analyse information derived from brain imaging and blood samples taken ...
-
Metlife foundation announces major awards to scientists for research in alzheimer`s disease
The 25th anniversary presentation of the MetLife Foundation Awards for Medical Research in Alzheimer's Disease (AD) was held today honoring two noted researchers, Randy L. Buckner, Ph.D., professor of Psychology and of Neuroscience at Harvard University and Howard Hughes Medical Institute Investigator, and Marcus E. Raichle, M.D., professor of radiology and neurology at Washington University ...
-
Pivalate’s additional data released from positive Phase II imaging trial in brain metastases
Sydney, Australia - November 23, 2022 - Radiopharm Theranostics (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that Imperial College London has released additional data related to the F-18 Pivalate (RAD 101) Phase 2a imaging trial in patients with brain metastases. High contrast images (see below) ...
-
Oxford Brain Diagnostics establishes a research-based clinical MRI study in Japan to investigate how Cortical Disarray Measurement (CDM) analysis may support differential diagnosis and estimate disease severity in Dementia patients
Oxford Brain Diagnostics Ltd, a software company focused on developing diagnostics based on changes in the brain at the cellular level, is delighted to announce that we have established a research collaboration with Principal Investigator Dr Takashi Nakajima, MD, PhD at Niigata Hospital and Dr Kazuo Shigematsu at Minami Kyoto National Hospital. In Japan, clinical MRI scanners are available for ...
-
Another good news for Deep01! Taiwan`s first AI product obtained marketing approval from Japan`s FDA
DeepCT - Intracranial Hemorrhage (ICH) AI Detection Software - developed by Taiwan's high-profile AI start-up team Deep01 - has obtained the marketing approval of Japan's PMDA, which is the first deep learning software officially licensed by Japan in Taiwan , marking a new milestone in Taiwan's AI medical output. Japan has the world's most aging population, and with advanced medical development, ...
-
SpinTech CEO Presents STAGE at MedTech Strategist Innovation San Francisco 2021
Ward Detwiler, our President & CEO, had the opportunity to speak about how STAGE is innovating the world of MR at MedTech Strategist Innovation 2021. ...
-
MassChallenge announces 30 digital health companies to join its 2019 cohort
At the end of the program the startups will get a chance to compete for more than $200,000 in prize money. Last week MassChallenge HealthTech unveiled the 30 digital health startups that will make up its 2019 cohort. The program gives the startups co-working office space and a tailored curriculum, with the primary goal of connecting startups to advisors, investors, pilots and research ...
By Epihunter NV
-
GE Researches dedicated MRI Brain Scanner Technology
Driving new technologies that will help expand the availability of MRI scanners beyond the hospital to smaller clinic settings, GE Global Research, the technology development arm for the General Electric Company (NYSE: GE), and Mayo Clinic, have received a five-year, $5.7 million grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Institute of ...
By GE Power
-
NFL & GE Announce Six Final Winners of $10 Million Head Health Challenge
Innovations are advancing the understanding and diagnosis of mild traumatic brain injury Breakthrough ideas include: point-of-care blood test to rapidly detect the presence of mild and moderate brain trauma; biomarkers that indicate how the brain reacts following a traumatic brain injury (TBI) and a method to identify which brain areas become disconnected after injury GE (NYSE: GE) and the ...
-
Longeveron Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer’s Disease in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biopharma company developing cellular therapies for aging-related illnesses, chronic disorders, and other specific life-threatening conditions, announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with mild Alzheimer’s disease (AD) in Alzheimer’s & Dementia®: The Journal of the ...
-
M Health Fairview University of Minnesota Medical Center Receives First Hyperfine Portable MRI to Grow its Advanced Imaging Systems Offering
Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine”), creator of the first U.S. Food and Drug Administration (“FDA”) cleared portable magnetic resonance imaging (“MRI”)TM device, Swoop®, is proud to announce that M Health Fairview is deploying a Swoop system in the emergency room (ER), intensive care unit (ICU) and post anesthesia environments at M Health Fairview ...
By Hyperfine
-
Arterys Partners With Cercare Medical to Offer Advanced Perfusion Brain CT and MR Imaging Analysis Accelerating Access to Deep, Fast, and Reliable Insights
SAN FRANCISCO, November 29, 2021 (Newswire.com) - Arterys, the world's leading vendor-neutral AI platform, today announced its partnership with Cercare Medical to make their AI-powered imaging solution, Cercare Perfusion, available on the Arterys Platform. Arterys has fully integrated the Cercare Perfusion solution which will be available via its FDA-cleared and CE marked MICA platform to its ...
By Arterys Inc.
-
AI ‘Fingerprinting’ Fights Back Against Hard-to-Detect Cancers
Hard-to-detect cancers like glioblastoma can have survival rates in the single-digit percentages and require elaborate techniques to detect, treat, and monitor. Reveal Surgical is working on changing that reality through its new, AI-based Sentry technology, which leverages a combination of AI and Raman spectroscopy to provide real-time tissue diagnostics during surgery for otherwise-invisible ...
-
Optina Diagnostics Closes an Oversubscribed Series-A Round of CA$24.8 million
2021 Optina, an innovative diagnostics company leading the field of Retinal Imaging, Brain Health and Systemic Diseases Diagnostics, announced today the closing of an CA$24.8 million Series A round of funding. Optina’s Retinal Deep Phenotyping™ platform obtained FDA Breakthrough Device Designation status in 2019 for its non-invasive and more accessible test to improve diagnosis ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you